Page last updated: 2024-09-05

lenalidomide and POEMS Syndrome

lenalidomide has been researched along with POEMS Syndrome in 57 studies

Research

Studies (57)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (3.51)29.6817
2010's41 (71.93)24.3611
2020's14 (24.56)2.80

Authors

AuthorsStudies
Cheng, YD; Guo, R; Jiang, ZX; Wan, DM; Wang, M; Zhang, JL1
Hountras, P; Lane, T1
Cheng, S; Fan, W; Ge, Y; Huang, L; Jiang, S; Liang, D; Zhu, X1
Aotsuka, Y; Kano, H; Kuwabara, S; Mimura, N; Misawa, S; Morooka, M; Nakamura, K; Ohwada, C; Otani, R; Sakaida, E; Sekiguchi, Y; Shibuya, K; Suichi, T; Takeda, Y; Tsukamoto, S1
Chiba, A; Honda, A; Ikemura, M; Kurokawa, M; Maki, H; Masamoto, Y; Oyama, T; Taoka, K1
Gong, D; Huang, W; Wang, Z; Yin, S; Zhou, K1
Hong, L; Huang, H; Lin, Z; Lu, J; Luo, L; Wang, C; Wang, X; Xu, R; Zhou, L1
Ikeda, S; Kameoka, Y; Kobayashi, T; Komatsuda, A; Saito, M; Takahashi, N; Ubukawa, K1
Agathokleous, A; Georgiou, S; Kyriakou, G; Marnellos, P; Solomou, EE; Symeonidis, A1
Amino, H; Iwai, Y; Katayama, K; Kuwabara, S; Misawa, S; Nagashima, K; Nakamura, K; Sato, Y; Sekiguchi, Y; Shibuya, K; Suichi, T; Suzuki, YI; Tsuneyama, A1
Arai, H; Handa, T; Ichikawa, M; Mitani, K; Nakamura, F; Nakamura, Y; Okazaki, A; Sasaki, K; Seo, S; Takahashi, W1
Dai, RP; Gao, XM; Li, J; Liu, LS; Zhang, X; Zhao, H; Zhou, DB1
Cao, X; Gao, X; Huang, X; Li, J; Xia, W; Yang, H; Zhao, H; Zhou, D1
Cai, H; Cai, QQ; Cao, XX; Gao, XM; Le, J; Li, J; Zhao, H1
Gao, Y; Li, J; Liu, Y; Wang, T; Yang, L; Zhang, S1
Khouri, J; Nakashima, M; Wong, S1
Abuomar, W; Al Sughaiyer, H; Al-Mayoof, O; Khan, M1
Collado-Borrell, R; Escudero-Vilaplana, V; González-Arias, E; Osorio-Prendes, S; Sanjurjo-Sáez, M1
Autore, F; Bacigalupo, A; Chiusolo, P; Innocenti, I; Laurenti, L; Luigetti, M; Piccirillo, N; Sica, S; Sora, F1
Akiyama, H; Hara, D; Hasegawa, Y; Hoshikawa, M; Nukui, S; Shimizu, T1
Adami, F; Briani, C; Gallia, F; Giordano, L; Merlini, G; Nobile-Orazio, E; Nozza, A; Santoro, A; Terenghi, F1
Boulard, C; Courville, P; Gremain, V; Langlois, V; Litrowski, N; Marguet, F; Zarnitsky, C1
Jaccard, A1
Hashida, H; Hatano, K; Irie, K; Matsumoto, H; Mitsutake, A; Tsukada, N1
Cai, H; Cai, QQ; Cao, XX; Gale, RP; Huang, XF; Li, J; Wang, C; Zhang, L; Zhao, H; Zhou, DB1
Khan, M; Stone, K; van Rhee, F1
Bianco, M; Fayoumi, MZ; Gallia, F; Giannotta, C; Nobile-Orazio, E; Nozza, A; Scarale, A; Terenghi, F1
Gilbert, L; Ordway, S; Wanko, S1
D'Sa, S; Keddie, S; Lunn, MP1
Cao, X; Huang, X; Li, J; Yang, H; Zhao, H; Zhou, D1
Bashir, Q; Champlin, RE; Delgado, R; Hosing, C; Kebriaei, P; Lee, HC; Manasanch, EE; Nieto, Y; Orlowski, RZ; Patel, KK; Patel, RD; Popat, U; Qazilbash, MH; Rondon, G; Saini, NY; Thomas, SK; Varma, A; Weber, DM1
Cai, H; Cao, XX; Feng, J; Gao, XM; Huang, XF; Li, J; Zhang, L; Zhao, H; Zhou, DB1
Chen, BY; Chen, WM; Liao, LS; Lin, Y; Qu, S; Wei, TN; Xie, Y; Zheng, ZH1
Kuwabara, S3
Fujita, C; Goto, A; Ibata, S; Ikeda, H; Iyama, S; Kato, J; Kikuchi, S; Kobune, M; Murase, K; Sugama, Y; Takada, K; Tatekoshi, A; Yoshida, M1
Anzai, T; Fukushima, A; Iwano, H; Matsuno, Y; Nakano, I; Naya, M; Oyama-Manabe, N; Shimizu, A; Takahashi, Y1
Boku, S; Hosoda, T; Kagoo, T; Kudo, M; Ohashi, K; Ueno, H; Yamamoto, R; Yano, T; Yokoyama, A; Yoneda, M1
Dimopoulos, MA; Gavriatopoulou, M; Kastritis, E; Psaltopoulou, T; Sergentanis, TN; Terpos, E; Zagouri, F1
Blin, N; Caristan, A; Connault, J; Duhamel, E; Graveleau, J; Hamidou, M; Le Gouill, S; Lestang, E; Maisonneuve, H; Masseau, A; Moreau, P; Néel, A; Touzeau, C1
Cai, H; Cai, QQ; Cao, XX; Li, J; Wang, C; Zhou, DB1
Campus, C; Ringuette, B; Robey, RC; Shumate, M1
Cai, QQ; Guan, YZ; Li, J; Su, W; Wang, C; Zhou, DB1
Cai, Q; Cao, X; Huang, X; Li, J; Wang, C; Yang, H; Zhou, D1
Cai, H; Cai, QQ; Cao, XX; Dai, RP; Huang, XF; Li, J; Zhang, X; Zhou, DB1
Arabi, H; Penumetcha, R; Sethi, S; Tageja, N1
Sucak, GT; Suyanı, E; Yağcı, M1
Giraldo, P; Lecumberri, R; Nistal, S; Tomás, JF1
Adami, F; Briani, C; Citton, V; Lessi, F; Manara, R; Zambello, R1
Fujita, Y; Furuta, N; Ikeda, M; Okamoto, K; Tashiro, Y1
Balducci, M; Chiusolo, P; De Stefano, V; Giannotta, C; Laurenti, L; Leone, G; Luigetti, M; Sabatelli, M; Sica, S; Sorà, F; Vannata, B1
Adam, Z; Hájek, R; Koukalová, R; Král, Z; Krejčí, M; Mayer, J; Nebeský, T; Pour, L; Rehák, Z; Szturz, P; Zahradová, L1
Fujisawa, S; Fujita, H; Imai, N; Ishigatsubo, Y; Matsuura, S; Ogusa, E; Taguchi, J; Tomita, N1
Abraham, J; Asli, B; Banos, A; Brisseau, JM; Choquet, S; Decaux, O; Deplanque, G; Facon, T; Fermand, JP; Galicier, L; Godmer, P; Guichard, I; Haroche, J; Hermine, O; Jaccard, A; Leblond, V; Leleu, X; Marolleau, JP; Merlusca, L; Musset, L; Recher, C; Roussel, M; Royer, B; Sebban, C1
Li, J; Zhou, DB1
Dispenzieri, A; Klein, CJ; Mauermann, ML1

Reviews

10 review(s) available for lenalidomide and POEMS Syndrome

ArticleYear
Coexistence of primary mediastinal MALT lymphoma and multiple myeloma like POEMS syndrome: A case report and literature review.
    Medicine, 2023, Jan-27, Volume: 102, Issue:4

    Topics: Bortezomib; Humans; Lenalidomide; Lymphoma, B-Cell, Marginal Zone; Multiple Myeloma; POEMS Syndrome; Rituximab; Thymus Neoplasms

2023
Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
    JAMA oncology, 2021, Sep-01, Volume: 7, Issue:9

    Topics: Humans; Lenalidomide; Monoclonal Gammopathy of Undetermined Significance; Paraproteinemias; POEMS Syndrome; Vascular Endothelial Growth Factor A

2021
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome.
    Hematological oncology, 2018, Volume: 36, Issue:2

    Topics: Angiogenesis Inhibitors; Biomarkers; Hematopoietic Stem Cell Mobilization; Humans; Lenalidomide; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Thalidomide; Transplantation, Autologous; Treatment Outcome; Vascular Endothelial Growth Factor A

2018
POEMS Syndrome: Therapeutic Options.
    Hematology/oncology clinics of North America, 2018, Volume: 32, Issue:1

    Topics: Allografts; Humans; Lenalidomide; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Radiotherapy; Thalidomide

2018
[Rapid improvement of fluid retention with lenalidomide plus low-dose dexamethasone for POEMS syndrome relapsed after autologous peripheral blood stem cell transplantation].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2013, Volume: 54, Issue:7

    Topics: Dexamethasone; Humans; Lenalidomide; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Secondary Prevention; Thalidomide; Transplantation, Autologous; Treatment Outcome

2013
Lenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis.
    Leukemia & lymphoma, 2014, Volume: 55, Issue:9

    Topics: Adult; Aged; Angiogenesis Inhibitors; Humans; Immunologic Factors; Lenalidomide; Middle Aged; POEMS Syndrome; Thalidomide; Treatment Outcome

2014
[Crow-Fukase (POEMS) syndrome].
    Brain and nerve = Shinkei kenkyu no shinpo, 2010, Volume: 62, Issue:4

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Humans; Immunoglobulin lambda-Chains; Lenalidomide; Melphalan; Paraneoplastic Syndromes, Nervous System; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Thalidomide; Transplantation, Autologous; Vascular Endothelial Growth Factor A

2010
[New treatment strategy for Crow-Fukase (POEMS) syndrome].
    Rinsho shinkeigaku = Clinical neurology, 2010, Volume: 50, Issue:11

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Boronic Acids; Bortezomib; Combined Modality Therapy; Demyelinating Diseases; Humans; Lenalidomide; Melphalan; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Pyrazines; Thalidomide; Transplantation, Autologous; Vascular Endothelial Growth Factor A

2010
[The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
    Vnitrni lekarstvi, 2012, Volume: 58, Issue:11

    Topics: Aged; Castleman Disease; Erdheim-Chester Disease; Female; Histiocytosis, Langerhans-Cell; Humans; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Thalidomide

2012
New advances in the diagnosis and treatment of POEMS syndrome.
    British journal of haematology, 2013, Volume: 161, Issue:3

    Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Boronic Acids; Bortezomib; Castleman Disease; Chromosome Aberrations; Combined Modality Therapy; Dexamethasone; Disease Management; Drug Therapy, Combination; Genes, Immunoglobulin; Humans; Hypertension, Pulmonary; Lenalidomide; Melphalan; Osteosclerosis; Peripheral Blood Stem Cell Transplantation; Plasma Cells; POEMS Syndrome; Prognosis; Pyrazines; Severity of Illness Index; Symptom Assessment; Thalidomide; Transplantation, Autologous; Vascular Endothelial Growth Factor A

2013

Trials

6 trial(s) available for lenalidomide and POEMS Syndrome

ArticleYear
Lenalidomide Treatment for Thalidomide-refractory POEMS Syndrome: A Prospective Single-arm Clinical Trial.
    Internal medicine (Tokyo, Japan), 2020, May-01, Volume: 59, Issue:9

    Topics: Dexamethasone; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Prospective Studies; Thalidomide; Treatment Outcome; Vascular Endothelial Growth Factor A; Young Adult

2020
Cereblon expression is a prognostic marker in newly diagnosed POEMS syndrome treated with lenalidomide plus dexamethasone.
    Annals of hematology, 2021, Volume: 100, Issue:6

    Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Anti-Inflammatory Agents; Biomarkers, Tumor; Dexamethasone; Female; Gene Expression; Humans; Immunologic Factors; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Prognosis; Prospective Studies; RNA, Messenger; Treatment Outcome; Ubiquitin-Protein Ligases; Up-Regulation; Young Adult

2021
Skin Responses in Newly Diagnosed Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome After Therapy With Low-Dose Lenalidomide Plus Dexamethasone.
    Frontiers in immunology, 2021, Volume: 12

    Topics: Adult; Aged; Biomarkers; Biopsy; Dexamethasone; Drug Therapy, Combination; Duration of Therapy; Female; Humans; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Skin; Symptom Assessment; Treatment Outcome; Vascular Endothelial Growth Factor A; Young Adult

2021
Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial.
    British journal of haematology, 2017, Volume: 179, Issue:5

    Topics: Adult; Aged; Angiogenesis Inhibitors; Dexamethasone; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Lenalidomide; Male; Middle Aged; Pilot Projects; POEMS Syndrome; Prospective Studies; Survival Analysis; Thalidomide; Treatment Outcome

2017
A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome.
    American journal of hematology, 2018, Volume: 93, Issue:6

    Topics: Adult; Aged; Dexamethasone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Remission Induction; Survival Analysis; Treatment Outcome; Vascular Endothelial Growth Factor A; Young Adult

2018
Improvement of thyroid function in POEMS syndrome after combination therapy of lenalidomide and dexamethasone.
    Leukemia & lymphoma, 2019, Volume: 60, Issue:2

    Topics: Adult; Aged; Biomarkers; Dexamethasone; Drug Therapy, Combination; Female; Humans; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Prognosis; Symptom Assessment; Thyroid Diseases; Thyroid Function Tests; Thyroid Gland; Time Factors; Treatment Outcome; Young Adult

2019

Other Studies

41 other study(ies) available for lenalidomide and POEMS Syndrome

ArticleYear
[The Clinical Characteristics and Outcomes of the Patients with POEMS Syndrome].
    Zhongguo shi yan xue ye xue za zhi, 2021, Volume: 29, Issue:5

    Topics: Aged; Aged, 80 and over; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Middle Aged; POEMS Syndrome; Retrospective Studies; Transplantation, Autologous

2021
A 65-Year-Old Man With Weight Loss, Peripheral Neuropathy, and Lower Extremity Swelling.
    Chest, 2022, Volume: 161, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Edema; Exercise Tolerance; Humans; Hypertension, Pulmonary; Lenalidomide; Male; Neoplasms, Plasma Cell; Peripheral Nervous System Diseases; Phosphodiesterase 5 Inhibitors; POEMS Syndrome; Positron Emission Tomography Computed Tomography; Stem Cell Transplantation; Syncope; Tadalafil; Weight Loss

2022
Efficacy of novel agents in patients with nephropathy associated with POEMS syndrome.
    International urology and nephrology, 2022, Volume: 54, Issue:9

    Topics: Adult; Dexamethasone; Endothelial Cells; Humans; Kidney Diseases; Lenalidomide; Middle Aged; POEMS Syndrome; Thalidomide; Vascular Endothelial Growth Factor A

2022
Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
    Internal medicine (Tokyo, Japan), 2022, Volume: 61, Issue:17

    Topics: Boron Compounds; Dexamethasone; Endocrine System Diseases; Glycine; Humans; Lenalidomide; Monoclonal Gammopathy of Undetermined Significance; POEMS Syndrome; Vascular Endothelial Growth Factor A

2022
Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion.
    International journal of hematology, 2023, Volume: 117, Issue:3

    Topics: Dexamethasone; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Male; Plasmacytoma; POEMS Syndrome; Thalidomide; Transplantation, Autologous

2023
POEMS syndrome: origination from clonal plasma cells or B cells?
    Hematology (Amsterdam, Netherlands), 2023, Volume: 28, Issue:1

    Topics: Aged; B-Lymphocytes; Humans; Lenalidomide; Male; POEMS Syndrome; Remission Induction; Vascular Endothelial Growth Factor A

2023
Multiparameter Flow Cytometry for the Identification of Neoplastic Plasma Cells in POEMS Syndrome with IgG-kappa Gammopathy: Successful Treatment Using Lenalidomide and Dexamethasone.
    Internal medicine (Tokyo, Japan), 2019, Dec-01, Volume: 58, Issue:23

    Topics: Aged; Dexamethasone; Flow Cytometry; Glomerulonephritis; Hemangioma; Humans; Immunoglobulin G; Immunoglobulin kappa-Chains; Immunologic Factors; Lenalidomide; Male; Paraproteinemias; Pigmentation Disorders; Plasma Cells; POEMS Syndrome; Treatment Outcome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2019
Reversal of skin changes in smoldering myeloma with clinical presentation of POEMS syndrome with a lenalidomide-based regimen.
    Annals of hematology, 2019, Volume: 98, Issue:11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Dyspnea; Edema; Humans; Lenalidomide; Male; Muscle Weakness; Nails, Malformed; POEMS Syndrome; Skin; Smoldering Multiple Myeloma

2019
[Effective treatment of POEMS syndrome accompanied by plasmacytoma with lenalidomide, dexamethasone, and local irradiation].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2020, Volume: 61, Issue:3

    Topics: Aged; Dexamethasone; Female; Humans; Lenalidomide; Plasmacytoma; POEMS Syndrome; Vascular Endothelial Growth Factor A

2020
Reliability of optic disc edema area in estimating the severity of papilledema in patients with POEMS syndrome.
    Orphanet journal of rare diseases, 2020, 05-19, Volume: 15, Issue:1

    Topics: Humans; Lenalidomide; Papilledema; POEMS Syndrome; Prospective Studies; Reproducibility of Results

2020
Endocrine Evaluation in POEMS Syndrome: A Cohort Study.
    Frontiers in endocrinology, 2020, Volume: 11

    Topics: Adrenal Insufficiency; Adult; Aged; Angiogenesis Inhibitors; Dexamethasone; Female; Humans; Hypogonadism; Hypothyroidism; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Young Adult

2020
POEMS syndrome: a rare cause of exudative ascites and chronic peripheral neuropathy.
    BMJ case reports, 2017, Jun-20, Volume: 2017

    Topics: Adult; Ascites; Dexamethasone; Humans; Lenalidomide; Male; Myeloma Proteins; Paraproteinemias; Peripheral Nervous System Diseases; Plasmacytoma; POEMS Syndrome; Sacrum; Thalidomide

2017
Eosinophilia secondary to lenalidomide therapy.
    Journal of clinical pharmacy and therapeutics, 2018, Volume: 43, Issue:2

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Hormonal; Cyclophosphamide; Dexamethasone; Eosinophilia; Female; Humans; Lenalidomide; Middle Aged; POEMS Syndrome; Thalidomide

2018
Utility of osteosclerotic lesion biopsy in diagnosis of POEMS syndrome: A case report.
    Medicine, 2017, Volume: 96, Issue:41

    Topics: Arthritis, Rheumatoid; Cell Proliferation; Diagnosis, Differential; Female; Humans; Immunoelectrophoresis; Immunologic Factors; Lenalidomide; Lupus Erythematosus, Systemic; Middle Aged; Neurologic Examination; Osteosclerosis; Plasma Cells; POEMS Syndrome; Sjogren's Syndrome; Thalidomide; Treatment Outcome

2017
Necrotizing autoimmune myopathy associated with POEMS syndrome report.
    QJM : monthly journal of the Association of Physicians, 2018, Jan-01, Volume: 111, Issue:1

    Topics: Autoimmune Diseases; Dexamethasone; Electromyography; Humans; Lenalidomide; Male; Middle Aged; Muscular Diseases; POEMS Syndrome; Thalidomide

2018
Lenalidomide-Induced Ischemic Cerebrovascular Disease in Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2018, Volume: 27, Issue:6

    Topics: Adult; Brain; Brain Infarction; Dexamethasone; Female; Humans; Immunologic Factors; Ischemic Attack, Transient; Lenalidomide; Oligopeptides; POEMS Syndrome; Thalidomide

2018
Daratumumab for POEMS Syndrome.
    Mayo Clinic proceedings, 2018, Volume: 93, Issue:4

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Lenalidomide; Middle Aged; POEMS Syndrome

2018
Clinical, electrophysiological and VEGF 2-year response after lenalidomide or stem cell transplantation in patients with POEMS syndrome.
    Journal of neurology, neurosurgery, and psychiatry, 2019, Volume: 90, Issue:3

    Topics: Action Potentials; Adult; Aged; Female; Humans; Immunologic Factors; Lenalidomide; Male; Middle Aged; Neural Conduction; POEMS Syndrome; Retrospective Studies; Stem Cell Transplantation; Treatment Outcome; Vascular Endothelial Growth Factor A

2019
POEMS syndrome: diagnostic delay and successful treatment with lenalidomide, cyclophosphamide and prednisone followed by autologous peripheral stem cell transplantation.
    BMJ case reports, 2018, Jul-26, Volume: 2018

    Topics: Adult; Combined Modality Therapy; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Dyspnea; Fatigue; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Lenalidomide; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Polyneuropathies; Prednisone; Thalidomide

2018
Advances in POEMS treatment and the need to define standardised outcome measures.
    British journal of haematology, 2019, Volume: 185, Issue:2

    Topics: Biomarkers; Humans; Lenalidomide; Melphalan; Outcome Assessment, Health Care; POEMS Syndrome; Thalidomide; Treatment Outcome; Vascular Endothelial Growth Factor A

2019
Long-term durable efficacy of autologous stem cell transplantation in POEMS syndrome.
    American journal of hematology, 2019, Volume: 94, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cyclophosphamide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Plasma Cells; Plasmapheresis; POEMS Syndrome; Prednisone; Retrospective Studies; Rituximab; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vincristine

2019
What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?
    Leukemia, 2019, Volume: 33, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dexamethasone; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Male; Melphalan; Middle Aged; POEMS Syndrome; Remission Induction; Retrospective Studies; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome

2019
[Autologous peripheral blood stem cell transplantation for POEMS syndrome].
    Zhonghua nei ke za zhi, 2019, Mar-01, Volume: 58, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Biomarkers; Cyclophosphamide; Dexamethasone; Humans; Lenalidomide; Melphalan; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Retrospective Studies; Transplantation, Autologous; Treatment Outcome; Vascular Endothelial Growth Factor A

2019
[Skin Changes in POEMS Syndrome].
    Brain and nerve = Shinkei kenkyu no shinpo, 2019, Volume: 71, Issue:4

    Topics: Humans; Lenalidomide; POEMS Syndrome; Skin; Thalidomide; Vascular Endothelial Growth Factor A

2019
[Treatment of POEMS syndrome with lenalidomide and dexamethasone].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2019, Volume: 60, Issue:4

    Topics: Dexamethasone; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; POEMS Syndrome; Randomized Controlled Trials as Topic; Transplantation, Autologous; Vascular Endothelial Growth Factor A

2019
POEMS Syndrome Showing Left Ventricular Dysfunction and Extracellular Edema Assessed by Cardiac Magnetic Resonance Imaging.
    Internal medicine (Tokyo, Japan), 2019, Sep-01, Volume: 58, Issue:17

    Topics: Cytokines; Dexamethasone; Drug Therapy, Combination; Edema; Female; Glucocorticoids; Humans; Lenalidomide; Magnetic Resonance Imaging; Middle Aged; POEMS Syndrome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Ventricular Dysfunction, Left

2019
Lenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome: a retrospective case series of eight patients.
    Leukemia & lymphoma, 2015, Volume: 56, Issue:6

    Topics: Aged; Angiogenesis Inhibitors; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Recurrence; Remission Induction; Retrospective Studies; Thalidomide; Time Factors; Treatment Outcome; Vascular Endothelial Growth Factor A

2015
Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome.
    European journal of haematology, 2015, Volume: 95, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dexamethasone; Female; Follow-Up Studies; Humans; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Recurrence; Thalidomide; Treatment Outcome

2015
POEMS syndrome: complex factors contributing to a delayed diagnosis.
    BMJ case reports, 2015, Nov-30, Volume: 2015

    Topics: Delayed Diagnosis; Dexamethasone; Diagnosis, Differential; Electromyography; Glucocorticoids; Humans; Immunologic Factors; Lenalidomide; Male; Middle Aged; Neural Conduction; POEMS Syndrome; Thalidomide

2015
Rapidly Progressive Polyneuropathy in a Patient With Monoclonal Gammopathy: A Case Report of POEMS Syndrome and Beyond.
    Medicine, 2016, Volume: 95, Issue:16

    Topics: Adult; Diagnosis, Differential; Disease Progression; Genetic Markers; Genetic Testing; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Lenalidomide; Male; POEMS Syndrome; Thalidomide

2016
Improvement of sexual function in POEMS syndrome after combination therapy of Lenalidomide and dexamethasone.
    Orphanet journal of rare diseases, 2016, 06-18, Volume: 11, Issue:1

    Topics: Adult; Aged; Dexamethasone; Female; Humans; Hypogonadism; Immunologic Factors; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Prospective Studies; Sexual Dysfunction, Physiological; Thalidomide; Young Adult

2016
OCULAR MANIFESTATIONS AND TREATMENT OUTCOMES IN CHINESE PATIENTS WITH POEMS SYNDROME.
    Retina (Philadelphia, Pa.), 2017, Volume: 37, Issue:9

    Topics: Adult; Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Dexamethasone; Female; Humans; Lenalidomide; Male; Middle Aged; Papilledema; POEMS Syndrome; Prospective Studies; Thalidomide; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Young Adult

2017
Lenalidomide therapy in a rare case of POEMS syndrome with kappa restriction.
    Southern medical journal, 2009, Volume: 102, Issue:10

    Topics: Antineoplastic Agents; Female; Humans; Immunoglobulin G; Immunoglobulin kappa-Chains; Lenalidomide; Middle Aged; POEMS Syndrome; Thalidomide

2009
Complete remission with a combination of lenalidomide, cyclophosphamide and prednisolone in a patient with incomplete POEMS syndrome.
    Acta haematologica, 2011, Volume: 126, Issue:4

    Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Gait Disorders, Neurologic; Glucocorticoids; Hand Deformities, Acquired; Humans; Lenalidomide; POEMS Syndrome; Prednisolone; Proteasome Inhibitors; Remission Induction; Thalidomide; Vascular Endothelial Growth Factors

2011
POEMS syndrome with severe neurological damage clinically recovered with lenalidomide.
    Haematologica, 2012, Volume: 97, Issue:2

    Topics: Adult; Aged; Female; Humans; Lenalidomide; Male; Middle Aged; Nervous System Diseases; POEMS Syndrome; Recovery of Function; Thalidomide; Treatment Outcome

2012
Pachymeningeal involvement in POEMS syndrome: dramatic cerebral MRI improvement after lenalidomide therapy.
    American journal of hematology, 2012, Volume: 87, Issue:5

    Topics: Aged; Castleman Disease; Clinical Trials as Topic; Dexamethasone; Drug Therapy, Combination; Humans; Lenalidomide; Magnetic Resonance Imaging; Male; Meninges; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Osteolysis; POEMS Syndrome; Prospective Studies; Thalidomide; Vascular Endothelial Growth Factor A

2012
[A case of POEMS syndrome associated with Waldenström's macroglobulinemia and treated with lenalidomide].
    Rinsho shinkeigaku = Clinical neurology, 2012, Volume: 52, Issue:3

    Topics: Humans; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Thalidomide; Waldenstrom Macroglobulinemia

2012
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation.
    American journal of hematology, 2012, Volume: 87, Issue:6

    Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Humans; Humerus; Immunologic Factors; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Osteosclerosis; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Prednisolone; Recurrence; Salvage Therapy; Thalidomide; Transplantation, Autologous

2012
[POEMS syndrome treated with lenalidomide plus high-dose dexamethasone as a pre-transplant induction therapy].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2012, Volume: 53, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Humans; Lenalidomide; Male; Middle Aged; Neoadjuvant Therapy; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Thalidomide

2012
Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patients.
    American journal of hematology, 2013, Volume: 88, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Positron-Emission Tomography; Radiography; Recurrence; Retrospective Studies; Thalidomide; Treatment Outcome; Vascular Endothelial Growth Factor A

2013
Lenalidomide therapy in a patient with POEMS syndrome.
    Blood, 2007, Aug-01, Volume: 110, Issue:3

    Topics: Adult; Antineoplastic Agents; Black or African American; Diagnosis, Differential; Humans; Interleukin-6; Lenalidomide; Male; POEMS Syndrome; Thalidomide; Time Factors; Vascular Endothelial Growth Factor A

2007
chemdatabank.com